In this study, a total of 12 genes, including TRAF, IRAK, TAB2, TLR, IL1R, and MYD88, harboured nonsilent mutations, indicating the activation of the NF-kB signalling pathway in tumour cells. This evidence concerns the gene NFKB1 and neoplasm.